On : 01 july 2025
• Global collagen-based wound dressings market size was valued at USD 423 million in 2024. The market is projected to grow from USD 453 million in 2025 to USD 676 million by 2032, exhibiting a CAGR of 7.1% during the forecast period.
Email: help@intelmarketresearch.com
• The global collagen-based wound dressings market is experiencing steady growth, driven by collagen’s proven effectiveness in promoting wound healing, reducing infection risk, and improving tissue regeneration. These dressings manufactured in forms such as gels, sponges, pads, and films are increasingly used in managing chronic wounds like diabetic foot ulcers, pressure injuries, burns, and surgical wounds. Innovation in composite formats (e.g., collagen combined with silver, hyaluronic acid, or growth factors) is expanding the applications and enhancing therapeutic outcomes. With an aging population, rising prevalence of diabetes, and increasing focus on advanced wound care, demand is particularly strong in North America and Europe. Asia-Pacific is emerging rapidly due to improving healthcare infrastructure, higher chronic disease incidence, and growing adoption of advanced biomaterials. Despite cost and regulatory barriers, collagen-based dressings are gaining momentum as a preferred therapeutic option in both inpatient and outpatient settings.
Email:
•Collagen Sheets/Patches
•Collagen Gels/Hydrogels
•Collagen Powders
•Collagen Sponges
•Composite Dressings
• Chronic wounds
• Subtypes: Diabetic foot ulcers, Pressure ulcers, Venous leg ulcers
• Acute wounds
• Subtypes: Surgical wounds, Traumatic wounds, Burns
• Dermatological conditions
Email: help@intelmarketresearch.com
•3M Company (U.S.)
•Angelini Pharma (Italy)
•Medline Industries, Inc. (U.S.)
•Integra LifeSciences Corporation (U.S.)
•Sanara MedTech Inc. (U.S.)
•Coloplast Corporation (Denmark)
•Covalon Technologies Ltd. (Canada)
•BSN Medical (Essity) (Germany)
Email: help@intelmarketresearch.com +91 9169164321
